.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
Baxter
US Army
Johnson and Johnson
UBS
Citi
Cipla
AstraZeneca
QuintilesIMS

Generated: December 12, 2017

DrugPatentWatch Database Preview

Medac Pharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for MEDAC PHARMA INC, and what generic alternatives to MEDAC PHARMA INC drugs are available?

MEDAC PHARMA INC has one approved drug.

There is one US patent protecting MEDAC PHARMA INC drugs.

There are twenty-four patent family members on MEDAC PHARMA INC drugs in nineteen countries.

Summary for Medac Pharma Inc

International Patents:24
US Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Medac Pharma IncRASUVOmethotrexateSOLUTION;SUBCUTANEOUS205776-006Jul 10, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medac Pharma IncRASUVOmethotrexateSOLUTION;SUBCUTANEOUS205776-002Jul 10, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medac Pharma IncRASUVOmethotrexateSOLUTION;SUBCUTANEOUS205776-009Jul 10, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medac Pharma IncRASUVOmethotrexateSOLUTION;SUBCUTANEOUS205776-003Jul 10, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medac Pharma IncRASUVOmethotrexateSOLUTION;SUBCUTANEOUS205776-001Jul 10, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medac Pharma IncRASUVOmethotrexateSOLUTION;SUBCUTANEOUS205776-004Jul 10, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medac Pharma IncRASUVOmethotrexateSOLUTION;SUBCUTANEOUS205776-008Jul 10, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medac Pharma IncRASUVOmethotrexateSOLUTION;SUBCUTANEOUS205776-007Jul 10, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medac Pharma IncRASUVOmethotrexateSOLUTION;SUBCUTANEOUS205776-005Jul 10, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medac Pharma IncRASUVOmethotrexateSOLUTION;SUBCUTANEOUS205776-010Jul 10, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Medac Pharma Inc Drugs

Country Document Number Estimated Expiration
Spain2355399► Subscribe
Russian Federation2403044► Subscribe
South Korea20090079876► Subscribe
European Patent Office2046332► Subscribe
Japan5683810► Subscribe
Austria14872► Subscribe
World Intellectual Property Organization (WIPO)2008009476► Subscribe
Germany202007019703► Subscribe
Russian Federation2009106053► Subscribe
Germany502007005972► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cipla
Fish and Richardson
Medtronic
Novartis
Argus Health
Dow
Cantor Fitzgerald
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot